Shire Inks $325M Deal For Blood Disorder Drug Co.
Irish pharmaceutical power Shire PLC beefed up its blood disorder treatment division Thursday with a $325 million deal to acquire privately held California-based FerroKin BioSciences Inc., which specializes in drugs that...To view the full article, register now.
Already a subscriber? Click here to view full article